OKYO Pharma Limited
- OKYO
- NASDAQ
- Biotechnology
- Inflammatory Eye Disease Therapies
- Preclinical Biopharma
$1.41
Today −1.40%Quote Oct 16, 2026, 08:00 PM UTC
+6.82%over the last month
Max drawdown −6.5%From 1-month high −4.1%3 months +2.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$74.0M
Quote Oct 16
Next earnings
Dec 2
Expected, not confirmed
Analyst target
$5.00
+254.6% from here
Floor
$1.35
4.2% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about OKYOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
5